2012 - Fellow of the American Association for the Advancement of Science (AAAS)
His primary areas of study are Internal medicine, Cardiology, Endocrinology, Pharmacology and QT interval. Many of his studies involve connections with topics such as MEDLINE and Cardiology. His research integrates issues of Mutation, Cardiomyopathy and Brugada syndrome in his study of Endocrinology.
His Pharmacology research integrates issues from Pharmacogenetics, VKORC1 and Warfarin. His work deals with themes such as Repolarization and Heart block, which intersect with QT interval. His Long QT syndrome study combines topics from a wide range of disciplines, such as Genetics, Sudden death and Bioinformatics.
Dan M. Roden spends much of his time researching Internal medicine, Cardiology, Pharmacology, Genetics and Atrial fibrillation. Dan M. Roden has included themes like Anesthesia and Endocrinology in his Internal medicine study. His work on Ventricular tachycardia, Electrocardiography, Heart disease and Sudden death as part of general Cardiology study is frequently linked to In patient, therefore connecting diverse disciplines of science.
His Pharmacology research focuses on Pharmacogenetics and how it connects with Pharmacogenomics. He combines subjects such as SNP, Genetic association and Bioinformatics with his study of Genome-wide association study. Particularly relevant to Long QT syndrome is his body of work in QT interval.
Dan M. Roden mainly focuses on Internal medicine, Genome-wide association study, Genetics, Bioinformatics and Cardiology. Internal medicine is closely attributed to Endocrinology in his study. Dan M. Roden interconnects SNP, Disease, Genetic association and Genomics in the investigation of issues within Genome-wide association study.
He works mostly in the field of Genetic association, limiting it down to topics relating to Computational biology and, in certain cases, Precision medicine and Brugada syndrome, as a part of the same area of interest. His studies in Bioinformatics integrate themes in fields like Phenotype and Phenome. His work carried out in the field of Odds ratio brings together such families of science as Confidence interval, Hazard ratio, Case-control study and Retrospective cohort study.
His primary scientific interests are in Internal medicine, Genome-wide association study, Genetics, Bioinformatics and Odds ratio. His studies examine the connections between Internal medicine and genetics, as well as such issues in Cardiology, with regards to Anesthesia. His study in Genome-wide association study is interdisciplinary in nature, drawing from both Phenome, Case-control study, Genetic association and Atrial fibrillation.
His Bioinformatics research includes themes of Drug development and Data science. His Odds ratio research incorporates elements of Genotyping and Confidence interval. In general QT interval, his work in Torsades de pointes and Long QT syndrome is often linked to Severe acute respiratory syndrome coronavirus 2 and 2019-20 coronavirus outbreak linking many areas of study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
Douglas P. Zipes;A. John Camm;Martin Borggrefe;Alfred E. Buxton.
Journal of the American College of Cardiology (2006)
Drug-induced prolongation of the QT interval.
Dan M. Roden.
The New England Journal of Medicine (2004)
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Bruce L. Wilkoff;James R. Cook;Andrew E. Epstein;Leon Greene.
JAMA (2002)
Guías de Práctica Clínica del ACC/AHA/ESC 2006 sobre el manejo de pacientes con arritmias ventriculares y la prevención de la muerte cardiaca súbita. Versión resumida.
Douglas P. Zipes;A. John Camm;Martin Borggrefe;Alfred E. Buxton.
Revista Espanola De Cardiologia (2006)
Estimation of the warfarin dose with clinical and pharmacogenetic data
Klein Te;Altman Rb;Eriksson N.
The New England Journal of Medicine (2009)
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Douglas B. Johnson;Justin M. Balko;Margaret L. Compton;Spyridon Chalkias.
The New England Journal of Medicine (2016)
The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.
R. B. Kim;M. F. Fromm;C. Wandel;B. Leake.
Journal of Clinical Investigation (1998)
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Douglas P. Zipes;A. John Camm;Martin Borggrefe;Alfred E. Buxton.
Europace (2006)
PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations.
Joshua C. Denny;Marylyn D. Ritchie;Melissa A. Basford;Jill M. Pulley.
Bioinformatics (2010)
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.
Barbara J. Drew;Michael John Ackerman;Marjorie Funk;W. Brian Gibler.
Journal of the American College of Cardiology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institutes of Health
University of Pennsylvania
Harvard University
University of Western Ontario
Northwestern University
Case Western Reserve University
University of Washington
University of Toronto
University of Washington
University of Manitoba
University of Melbourne
Stevens Institute of Technology
The University of Texas at San Antonio
Tokyo University of Technology
Duke University
Okayama University
University of Illinois at Urbana-Champaign
University of Minnesota
University of Graz
University of Southampton
TU Dresden
University of Sydney
Sun Yat-sen University
University Hospital of Basel
University of Wyoming
University of Toronto